Large Molecule Bioanalytical Testing Services Market Will See Strong Expansion Through 2030: Grand View Research Inc.

 Large Molecule Bioanalytical Testing Services Market Growth & Trends

The global large molecule bioanalytical testing services market size is expected to reach USD 3.5 billion by 2030, registering a CAGR of 9.1% over the forecast period, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Request a free sample copy or view the report summary: Large Molecule Bioanalytical Testing Services Market Report

Large Molecule Bioanalytical Testing Services Market Report Highlights

• The clinical segment dominated the global industry in 2021. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth
• The ADA-type segment dominated the global industry in 2021 and accounted for the largest share of the overall revenue
• Bioavailability was the largest test segment share in 2021 on account of the increasing adoption in generic drug manufacturing
• The oncology segment held the largest revenue share in 2021 due to the increasing prevalence of cancer globally
• Asia Pacific is projected to witness the fastest CAGR during the forecast years due to the rising healthcare expenditure, particularly in India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-large-molecule-bioanalytical-testing-service-market

Large Molecule Bioanalytical Testing Services Market Segmentation

Grand View Research has segmented the global large molecule bioanalytical testing services market based on phase, type, test type, therapeutic areas, end-user, and region:

Large Molecule Bioanalytical Testing Services Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical
  • With Antibody
  • Without Antibody (ELISA Based Assay)
• Clinical

Large Molecule Bioanalytical Testing Services Type Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmacokinetics
• ADA
• Others

Large Molecule Bioanalytical Testing Services Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• ADME
• PD
• Bioavailability
• Bioequivalence
• Other Tests

Large Molecule Bioanalytical Testing Services Therapeutic Areas Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Infectious Diseases
• Cardiology
• Neurology
• Others

Large Molecule Bioanalytical Testing Services End-user Outlook (Revenue, USD Million, 2018 - 2030)

• SMEs
  • CROs & CMOs
  • Sponsor Organizations
  • Others (Academic Institute, etc.)
• Large Firms
  • CROs & CMOs
  • Sponsor Organizations
  • Others (Academic Institute, etc.)

Large Molecule Bioanalytical Testing Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Large Molecule Bioanalytical Testing Services Market

• Covance
• IQVIA
• Syneos Health
• SGS SA
• Toxikon
• Intertek Group plc
• Pace Analytical Services LLC
• ICON Plc
• Charles River Laboratories
• Thermo Fisher Scientific

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Sleep Apnea Devices Market to Reach Around USD 6.9 Billion by 2030: Grand View Research Inc.

 Sleep Apnea Devices Market Growth & Trends

The global sleep apnea devices market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.2% from 2023 to 2030. The growing prevalence of chronic disorders such as hypertension, diabetes, cardiovascular diseases, and obesity is increasing the incidence rate & burden of Obstructive Sleep Apnea (OSA).

According to World Population Review estimates, the prevalence of obesity in the U.S. accounts for 36.2% of the total population. As per studies, the prevalence of OSA increases with increasing age. The growing global geriatric population with increasing life expectancy is anticipated to contribute to the growing prevalence of OSA. Low awareness levels and poor penetration of apnea devices in developing and underdeveloped nations introduce potential growth opportunities.

The COVID-19 pandemic imposed multiple lockdowns and travel restrictions leading to significant disruptions in the functioning of healthcare facilities. Several healthcare facilities underwent significant infrastructural changes and healthcare providers were forced to postpone elective procedures. The pandemic impacted the procedural volume and led to the temporary shutdown of sleep centers, clinics, and physician practices. These measures to curb the transmission rate of coronavirus negatively impacted the diagnostics market growth.

However, therapeutic devices such as sleep & respiratory care witnessed a surge in demand during the initial months of the pandemic. Positive Airway Pressure devices were being used as an alternative to mechanical ventilation instead of ventilators.

Key players are constantly focusing on devising innovative product development strategies to serve the growing diagnostic and therapeutic demand which is driving growth. Furthermore, innovative alternatives to CPAP such as oral and nasal devices are being introduced for patients with a low tolerance for CPAP.

For instance, GoPAPFree, a manufacturer of homecare oral devices introduced O2Vent Optima in February 2021 as a convenient & more effective alternative to CPAP. Similarly, Fisher & Paykel launched F&P Evora with CapFit headgear in February 2020 which is a compact nasal mask used in sleep apnea treatment for European, Canadian, Australian, and New Zealand markets.

Request a free sample copy or view the report summary: Sleep Apnea Devices Market Report

Sleep Apnea Devices Market Report Highlights

• The therapeutic devices segment held the largest revenue share of 79.2% in 2022
• North America accounted for the largest revenue share of 48.4% in 2022, owing to the growing prevalence of OSA, rising awareness levels, and presence of renowned players
• Asia Pacific is expected to witness the fastest CAGR of over 7.7% from 2023 to 2030, owing to the prevalence of OSA and the rising awareness in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sleep-apnea-devices-market

Sleep Apnea Devices Market Segmentation

Grand View Research has segmented the global sleep apnea devices market based on product type and region:

Sleep Apnea Product Type Outlook (Revenue, USD Million, 2016 - 2030)

• Diagnostic Devices
  • Actigraphs
  • Polysomnography (PSG) devices
  • Respiratory Polygraphs
    • Cardiologists
    • ENT Specialists
    • Homecare Nurses
    • Sleep Physicians
  • Pulse Oximeters
• Therapeutic Devices
  • Positive Airway Pressure (PAP) Devices
    • CPAP
    • APAP
    • Bi-PAP
  • Oral Devices
  • Nasal Devices
  • Chin Straps
• Sleep Apnea Masks

Sleep Apnea Devices Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Portugal
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • A.E.

List of Key Players in the Sleep Apnea Devices Market

• ResMed
• Phillips Respironics
• Fisher & Paykel Healthcare Limited
• Curative Medical, Inc.
• Invacare Corporation
• Somnetics International, Inc.
• BMC Medical Co., Ltd.
• Natus Medical Incorporated
• SOMNOmedics GmbH
• Compumedics Limited
• Itamar Medical Ltd.
• Nihon Kohden Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ambient Commerce Market Trends, Company Share, Industry Growth And Future Scope: Grand View Research Inc.

 Ambient Commerce Market Growth & Trends

The global ambient commerce market size is expected to reach USD 65.82 billion by 2030, expanding at a CAGR of 33.6% from 2022 to 2030, according to a new report by Grand View Research, Inc. Ambient commerce helps retailers streamline their shops by automizing their checkout processes. Ambient commerce uses various advanced technologies to completely automate the customer shopping experience.                                                                                         

Businesses and retailers are putting a strong emphasis on leveraging the latest technologies such as Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT). Retailers are integrating these technologies into their operations to automate and streamline their business processes and offer customers a rich shopping experience. Ambient commerce provides contactless shopping options to customers, thereby driving the market.

Ambient commerce technology tracks shelf and storage data in a store by tracking the movement of products or customers. Due to this, it provides retailers with automated data, helping them in product restocking and warehouse management. The shelf data in retail stores provided by ambient commerce streamlines the supply chain of retail stores, which is driving its adoption among retailers.

The COVID-19 pandemic has highlighted the need for updating traditional business models to sustain the changing business environment. Moreover, the growing consumer preference for contactless and quick shopping methods during the pandemic is driving the adoption of ambient commerce. Retailers are adopting advanced technologies such as ambient products to entice consumers to shop from brick-and-mortar stores instead of online shopping, which bodes well for the market growth.

Request a free sample copy or view report summary: Ambient Commerce Market Report

Ambient Commerce Market Report Highlights

• The cameras segment is expected to witness significant growth over the forecast period. Cameras capture the movements of customers to identify which products they have bought from the shelves and which they have put back. Cameras play a significant role in ambient commerce in automating the checkout process, thus driving the segment
• The supermarkets segment is expected to witness the fastest growth over the forecast period. Supermarkets are implementing new technologies to offer a contactless shopping experience owing to the recent outbreak of the COVID-19 virus. Supermarkets are adopting contactless payments, outdoor payment terminals, self-checkout, and ambient commerce to drive the digital transformation of retail stores. The growing adoption of ambient shopping is fueling the growth of the segment
• Asia Pacific is anticipated to emerge as the fastest-growing region over the forecast period owing to a broader customer base and a substantial number of key players and innovators in the region. Additionally, countries such as China, Japan, and South Korea are adopting new technologies to automate their retail business processes, which, in turn, bodes well for the regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ambient-commerce-market

Ambient Commerce Market Segmentation

Grand View Research has segmented the global ambient commerce market on the basis of component, end-use, and region:

Ambient Commerce Component Outlook (Revenue, USD Million, 2017 - 2030)

• Sensors
• Actuators
• Cameras
• Others

Ambient Commerce End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Grocery Stores
• Convenience Stores
• Supermarkets
• Department Stores
• Others

Ambient Commerce Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia

List of Key Players of Ambient Commerce Market

• Apple Inc.
• com, Inc.
• Alibaba Group Holding Limited
• Trigo Vision Ltd.
• com
• AWM SMART SHELF
• Grabango Co.
• Zippin
• Standard AI
• Sensei

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hydrolase Enzymes Market Key Players ,Industry Share ,Growth, And Forecast To 2030: Grand View Research Inc.

 Hydrolase Enzymes Market Growth & Trends

The global hydrolase enzymes market size is expected to reach USD 9.82 billion by 2030, as per the new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 6.6% from 2022 to 2030. The growth is majorly driven by the rising global consumption of bakery products and fruit juices across the globe. The product is also used for manufacturing artificial sweeteners and prebiotic products such as isomaltose for juices and wines.

The hydrolase enzymes industry is established with major applications in food & beverages, pharmaceuticals, laundry detergent, and personal care & cosmetics sectors. The market is primarily driven by growing demand from the brewing and dairy industries. The growth market can also be attributed to a shift in consumer preferences concerning processed and packaged foods due to the increasing awareness of food security & safety.

North America is a prominent market for hydrolase enzymes due to the presence of numerous manufacturers catering to various end-user industries including pharmaceuticals, laundry detergent, food & beverage, and personal care & cosmetics along with the high scope for R&D activities in major countries of the region. The rising demand for the product to improve the nutritional content of the feed is likely to emerge as one of the key factors driving the product demand in the region.

Moreover, the outbreak of the COVID-19 pandemic has led to a significant rise in the demand for hydrolase enzymes in the food & beverage industry as consumers have become highly aware of the importance of healthy, nutritious, and safe eating. Along with the increased demand for ingredients, food enzyme manufacturers have also expanded their production capacity to meet the growing demand.

Request a free sample copy or view report summary: Hydrolase Enzymes Market Report

Hydrolase Enzymes Market Report Highlights

• Peptidase is the fastest growing product segment with a CAGR of 7.1 % based on the product’s ability to enhance the extraction process, yield, and texture of fruit juices
• Pharmaceutical application is the fastest growing segment with a CAGR of 7.2% owing to the growing population, high consumer demand, and rising awareness regarding diseases
• Europe is the fastest growing region with a CAGR of 7.3% due to the strong presence of prominent manufacturers in the food & beverage, pharmaceuticals, and personal care & cosmetics, and laundry detergent industries
• Challenges faced by the industry comprise high sensitivity of enzymes to pH and temperature coupled with product handling security problems
• The market players are constantly involved in strategic initiatives such as mergers & acquisitions, new product development, and capacity enhancement to gain a competitive edge in the market. For example, in April 2021, BASF SE merged with Sandoz GmbH, a subsidiary of Novartis, to invest in its Kundl/Schaftenau Campus in Austria. This move is expected to lead to an increase in the production capacity and product portfolio of BASF SE in the biotechnology and hydrolase enzymes segment

Access Press Release@ https://www.grandviewresearch.com/press-release/global-hydrolase-enzymes-market

Hydrolase Enzymes Market Segmentation

Grand View Research has segmented the global hydrolase enzymes market based on product, application, and region:

Hydrolase Enzymes Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Esterase
• Glycosylases
• Peptidases
• Others

Hydrolase Enzymes Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Pharmaceutical
• Food & Beverages
• Laundry Detergents
• Cosmetics
• Textile
• Pulp and Paper
• Biofuel
• Others

Hydrolase Enzymes Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
  • Denmark
  • The Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players in the Hydrolase Enzymes Market

• Creative Enzymes
• Advanced Enzyme Technologies
• Infinita Biotech Private Limited
• Antozyme Biotech Pvt. Ltd.
• Novozymes
• Specialty Enzymes & Probiotics
• Aumgene Biosciences

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Web 3.0 Blockchain Market Latest Innovations, Drivers and Industry Key Events 2023– 2030: Grand View Research Inc.

 Web 3.0 Blockchain Market Growth & Trends

The global Web 3.0 blockchain market size is expected to reach USD 33.53 billion by 2030, growing at a CAGR of 47.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The ability of web 3.0 to authorize the users to use the decentralized blockchain technology for accessing the decentralized applications is the major factor driving the market growth. Web 3.0 provides perception based on the users’ search content and allows them to control their data on websites.

Web 3.0 technology is also used in social network platforms that aim to improve the customer experience, such as how customers communicate, interact and form communities. Rising investments in Web 3.0 blockchain technology to expand its application is a significant factor driving the growth of the industry. For instance, according to the statistics of Venture Intelligence, a financial analysis company, Web 3.0 and crypto startups have raised more than USD 1 billion in funding across 43 deals in the first six months of 2022.

Numerous companies across the globe are also focusing on launching Web 3.0 practices to help startups scale their businesses and develop innovative solutions. For instance, in July 2022, KiwiTech, an innovation ecosystem company, launched a Web 3.0 Center of Excellence service to empower the next-generation blockchain innovations for startup companies. Such a launch of services is expected to create lucrative growth opportunities for the market during the forecast period.

The COVID-19 pandemic is expected to have a positive impact on the market. As the pandemic continues, online shopping at e-commerce sites and the frequency of online payments have increased. As online shopping continued, the adoption of Web 3.0 blockchain technology for making online payments also increased as blockchain technology facilitates faster transactions and improved security. Moreover, the growing adoption of blockchain technology applications in smart contracts and cryptocurrencies is also expected to contribute to the industry’s growth.

Request a free sample copy or view report summary: Web 3.0 Blockchain Market Report

Web 3.0 Blockchain Market Report Highlights

• The public segment dominated the market in 2022. The growth of the segment can be attributed to the increased demand for public blockchain technology owing to the free, secure, and permissionless accessibility to anyone with internet access
• The cryptocurrency segment dominated the market in 2022. Enterprises are increasingly in need of high-performance cryptocurrency transaction services. Web 3.0 cryptocurrencies use blockchain and smart contracts to automate transactions and eliminate the need for a third-party entity which is anticipated to support the segment's growth
• The retail & e-commerce segment is anticipated to register the fastest growth during the forecast period. Increasing demand for Web 3.0 blockchain in retail & e-commerce owing to benefits such as reduced costs, faster payments, improved security, and increased transparency is expected to fuel the segment's growth
• The Asia Pacific is anticipated to witness the fastest growth during the projection period. The increasing advancements in 5G, artificial intelligence, and machine learning is the major factor driving the growth of the Asia Pacific region. Moreover, growing investments in research & development of Web 3.0 is anticipated to aid the growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-web-3-0-blockchain-market

Web 3.0 Blockchain Market Segmentation

Grand View Research has segmented the global Web 3.0 blockchain market based on blockchain type, application, end-use, and region:

Web 3.0 Blockchain Type Outlook (Revenue, USD Million, 2019 - 2030)

• Public
• Private
• Consortium
• Hybrid

Web 3.0 Blockchain Application Outlook (Revenue, USD Million, 2019 - 2030)

• Cryptocurrency
• Conversational AI
• Data & Transaction Storage
• Payments
• Smart Contracts
• Others

Web 3.0 Blockchain End-use Outlook (Revenue, USD Million, 2019 - 2030)

• BFSI
• Retail & E-commerce
• Media & Entertainment
• Pharmaceuticals
• IT & Telecom
• Others

Web 3.0 Blockchain Regional Outlook (Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • Saudi Arabia
  • UAE

List of Key Players in the Web 3.0 Blockchain Market

• Web3 Foundation (Polkadot)
• Helium Systems Inc
• Ocean Protocol Foundation Ltd.
• Zel Technologies Limited.
• Kusama
• Livepeer, Inc.
• Filecoin
• Kadena LLC
• Polygon technology
• Terra

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cellular Health Screening Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 

Cellular Health Screening Market Growth & Trends

The global cellular health screening market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.2% from 2022 to 2030. The growing geriatric population and consequent growth in the requirement for cellular health screening are majorly driving the market. In addition, the rising adoption of the direct-to-consumer approach, the growing importance of healthy life expectancy (HALE), increasing telomere performance programs for leading a healthy life, and rising government focus on preventive healthcare are expected to drive the market.

An increasing number of individuals undergoing cellular health screening testing, such as telomere tests, to learn about the biomarkers of cell aging is also anticipated to supplement the market growth. It has been demonstrated that tests that provide information on telomere length and activity can also provide information on lifestyle and stress factors. Numerous studies have demonstrated that both acute stress and chronic stress accelerate cell aging. Thus, these tests play an important role in understanding one’s health.

Additionally, researchers can gain insights into cellular qualities by studying how physical exercise, sleep, mental health issues, alcohol use, and smoking habits alter cellular aging in various ways. The utilization of telomere tests offers insights into metabolic and genetic illnesses, enabling clinicians to make an early diagnosis and quickly and individually tailor a patient's treatment regimen. Consequently, growing interest in cellular screening and expanding research have increased kit and test demand, facilitating market growth in recent years.

The necessity for cellular screening research has grown as a result of its many applications in preventive medicine and the capacity to comprehend relationships between telomere length and aging. Bio-cell-based screenings are frequently advised throughout time, allowing patients to compare results and comprehend what modifications need to be made. Monitoring these alterations in cellular health between screenings enables quick adjustments to be made in terms of health protocols and a general improvement in illness management.

Furthermore, disorders related to aging are linked to the buildup of old, dysfunctional cells. As shown in several animal trials, research has recently established that these can be reversed by employing a variety of cellular health procedures. Consequently, it is anticipated that ongoing research and development activities in the disciplines of protein expression, proteomics, and genomics are anticipated to further boost the demand for cellular health screening products in the near future.

Request a free sample copy or view report summary: Cellular Health Screening Market Report

Cellular Health Screening Market Report Highlights

• By test type, single test panels held the largest share in 2021. This is attributed to high specificity, easy customization, and increasing product availability in the market
• In the single test panels segment, the oxidative stress tests captured the largest share in 2021. These tests aid in cancer, respiratory diseases, diabetes, cardiovascular diseases, and other diseases
• Based on sample type, the blood sample segment accounted for the largest share in 2021. The growing incidence of infectious diseases, emergence of newer pathogens, increasing demand for donated blood, and rising number of blood donations have contributed to the rising demand for blood samples for cellular health screening
• By collection site, hospitals captured the largest revenue share in 2021. A major part of the general population relies on these long-term facilities for diagnosis, treatment, and management of diseases, thus driving the segment
• North America accounted for the largest market share in 2021. An increase in the importance of Healthy Life Expectancy (HALE) and increasing number of government initiatives focused on preventive healthcare are some of the key factors expected to boost the market growth in the region
• Asia Pacific is expected to witness the fastest growth throughout the forecast period. Improving adoption and awareness of telomere performance programs and growing awareness of healthy life expectancy have contributed to regional growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cellular-health-screening-market

Cellular Health Screening Market Segmentation 

Grand View Research has segmented the global cellular health screening market based on test type, sample type, collection site, and region:

Cellular Health Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Single Test Panels
  • Telomere Tests
  • Oxidative Stress Tests
  • Inflammation Tests
  • Heavy Metals Tests
• Multi-test Panels

Cellular Health Screening Sample Type Outlook (Revenue, USD Million, 2018 - 2030)

• Blood
• Saliva
• Serum
• Urine

Cellular Health Screening Collection Site Outlook (Revenue, USD Million, 2018 - 2030)

• Home
• Office
• Hospital
• Diagnostic Labs

Cellular Health Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Cellular Health Screening Market

• Telomere Diagnostics
• SpectraCell Laboratories
• Life Length
• Repeat Diagnostics, Inc.
• Cell Science Systems Corp.
• Quest Diagnostics
• LabCorp Holdings
• OPKO
• Genova Diagnostics
• Immundiagnostik AG
• DNA Labs

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Finance Lease Market Significant Profits Estimated to be Generated by 2030: Grand View Research Inc.

 Finance Lease Market Growth & Trends

The global finance lease market size is expected to reach USD 324.40 billion by 2030, growing at a CAGR of 5.1% from 2022 to 2030, according to a new study conducted by Grand View Research, Inc. The market is anticipated to be driven by several advantages offered by finance leasing over traditional borrowing methods, including higher margins, tax advantages, and inflation-friendly and secure investments. Furthermore, the massive demand for new commercial models and branded equipment across the globe has become one of the significant factors driving the growth.

Benefits offered by leasing finance company services to lessees such as temporary occupant of the property, cost-effective method of acquiring assets, and others drive the market growth. Furthermore, it helps to free up working capital enabling the lessee to spend on its core tasks. On the other hand, the lessor, the legal owner of the asset or property, can recoup the cost of the asset and earn interest on the rental payments by the lessee.

The finance lease accounting assists businesses with capital constraints in obtaining highly-priced assets. The finance lease market still faces a few market constraints, such as the risks associated with exchange rate fluctuations. Furthermore, the difficulties encountered due to varying regulatory scenarios in different countries may also prevent finance lease service providers from offering global finance lease services.

The global COVID-19 pandemic has been favorable to market growth. Finance leasing has allowed SMEs and other businesses to grow significantly with the assistance of leasing options. Furthermore, the growing tendency of companies to finance equipment and software, aided by the Federal Reserve's interest rate reductions, is expected to create new growth opportunities for the finance leasing industry during the forecast period.

Request a free sample copy or view report summary: Finance Lease Market Report

Finance Lease Market Report Highlights

• The international business segment is expected to witness significant growth during the forecast period. The need for businesses to reduce cost and capital requirements for equipment and the ability to adapt to rapidly changing technological advancements is driving the segment growth
• The non-bank segment is expected to witness significant growth during the forecast period. Greater flexibility on interest rates and quick approvals of financing solutions offered by such institutions are driving their demand among start-ups and small businesses
• The IT & telecom segment dominated the market in 2021. Telecom and media companies are constantly aiming to grow their infrastructure to match the ever-changing market demands, which is anticipated to drive the growth of the segment
• The Asia Pacific is expected to register rapid growth during the forecast period. The rising popularity and awareness of finance leasing options across the region are expected to drive the development of the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-finance-lease-market

Finance Lease Market Segmentation

Grand View Research has segmented the global finance lease market based on product, type, application, and region:

Finance Lease Product Outlook (Revenue, USD Billion, 2017 - 2030)

• International Business
• Domestic Business

Finance Lease Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Banks
• Non-banks

Finance Lease Application Outlook (Revenue, USD Billion, 2017 - 2030)

• Transportation
• Medical Devices
• Energy & Environment
• Construction Equipment
• Industrial Machinery
• IT & Telecom
• Others

Finance Lease Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)

List of Key Players in the Finance Lease Market

• Sumitomo Mitsui Finance and Leasing Co., Ltd.
• BNP Paribas Leasing Solutions
• HSBC Group
• Wells Fargo Bank N.A.
• Texas Capital Bancshares, Inc.
• Commerce Bancshares, Inc.
• Fifth Third Bank
• Bank of America Corporation
• Crest Capital
• North Star Leasing

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sustained Release Excipients Market is Expected to Enhance USD 2.4 Billion Revenue By 2030: Grand View Research Inc.

 Sustained Release Excipients Market Growth & Trends

The global sustained release excipients market size is expected to reach USD 2.4 billion by 2030, registering a CAGR of 8.22% over the forecast period, according to a new report by Grand View Research, Inc. Rise in the number of patent expirations, need for pediatric & geriatric dosage forms, and added benefits provided by sustained release formulations are factors that are positively contributing to the market potential. Sustained release formulations significantly reduce dosage frequency and improve patient compliance. These factors are further aiding industry growth. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits.

Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained release formulations, enabling higher patient compliance and improved therapeutic effect.

Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.

The use of controlled release formulations has been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice of formulations among physicians, which increases their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may have a more substantial impact on the oral solid dosage form drug manufacturing.

This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for growth of the industry in Europe, which includes France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, the presence of sophisticated healthcare infrastructure, and a rise in the number of product approvals are the factors expected to create growth opportunities in the Europe region.

Sustained release formulations are designed specifically in ways to reduce the dosage frequency. Thus, these formulations have high Active Pharmaceutical Ingredient (API) doses, which facilitate the maintenance of desired therapeutic levels. However, drug toxicity resulting from sustained release formulations is difficult to treat due to excess API. Drug retrieval in these cases becomes difficult as drugs are designed to deliver predetermined amounts at frequent time intervals. These are very rarely seen in sustained release formulations, which may hinder industry growth to a certain extent.

Request a free sample copy or view report summary: Sustained Release Excipients Market Report

Sustained Release Excipients Market Report Highlights

• The polymers product segment accounted for the largest share in 2021. Varied usage of polymers in sustained release formulations is anticipated to fuel industry growth
• Conventional use of the oral route of delivery has contributed to the segment's growth. Convenience, in terms of storage, premeasured doses, portability, and noninvasive nature of this route are some of the major factors accelerating its adoption
• The rising adoption of transdermal patches has contributed to the growth of the segment
• Targeted drug delivery constituted the largest revenue share in 2021, as a large number of industry players have strong product portfolios. Implantable sustained release drug delivery systems have improved efficiency, lower adverse effects, and higher convenience, which impels segment growth
• Europe dominated the global industry in 2021 due to the high investments in R&D and availability of highly sophisticated technologies in the region
• Asia Pacific will register the fastest CAGR during the forecast period due to the growing pharmaceutical industry in emerging countries, such as India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sustained-release-excipients-market

Sustained Release Excipients Market Segmentation

Grand View Research has segmented the global sustained release excipients market based on product, route of administration, technology, and region:

Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)

• Gelatin
• Polymers
• Minerals
• Sugars
• Alcohol
• Chitosan

Sustained Release Excipients Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Vaginal
• Ophthalmic
• Intravenous
• Other Route of Administrations

Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Targeted Delivery
• Micro Encapsulation
• Wurster Technique
• Transdermal
• Implants
• Coacervation
• Others

Sustained Release Excipients Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Sustained Release Excipients Market

• BASF
• International Flavors & Fragrances, Inc.
• Ashland Global
• Evonik Industries
• Croda International Plc
• Gattefossé
• Merck KGaA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market For Genetic Toxicology Testing to Witness Tremendous Growth and Expansion by 2030

 Genetic Toxicology Testing Market Growth & Trends

The global genetic toxicology testing market size is expected to reach USD 3.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 12.7% from 2022 to 2030. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product.

Increasing implementation of pharmacogenomics to support personalized medicine usage and reduced risk of adverse drug toxicity is considered to have a significant impact on the growth of the industry.

Moreover, organizations, such as the Dutch Pharmacogenetics Working Group (DPWG), Clinical Pharmacogenetics Implementation Consortium (CPIC), the French National Network of Pharmacogenetics, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), have issued clinical guidelines with a primary focus on the pharmacogenomics testing interpretation and recommendation on therapeutic specific drug-gene pairs.

Similarly, the market players are indulging in various strategies to expand their footprint in multiple segments. For instance, in November 2021, Labcorp announced the acquisition of Toxikon, a Contract Research Organization (CRO) with offerings in nonclinical testing services. Through this acquisition, Labcorp is anticipated to strengthen its toxicology business and Toxikon’s location enables Labcorp to engage with known biotech and pharmaceutical companies in the region for non-clinical work.

The COVID-19 pandemic is anticipated to have a neutral impact on the genetic toxicology testing market growth. Numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus. The genetic toxicology of various drugs and chemicals was assessed. Such studies using genetic toxicology testing as a tool of assessment are anticipated to support stable growth during the peak of COVID-19.

The rising demand for novel food and its imports is expected to be a contributor to market growth. Charles River Laboratories is one of the major players offering toxicology assessments on novel foods. They offer novel food analysis including genotoxicity, which consist of in vivo micronucleus test, Ames study, In Vitro Mammalian Cell Micronucleus, and in the vivo comet assay. Similarly, in January 2021, EFSA published its evaluation of insect-derived food. It is the first kind of assessment conducted by the institution on the insect product as a novel food. Every year, EFSA receives a large number of applications, consisting of herbal products based on algae foods, plants, and non-indigenous fruits.

On the other hand, the ability to retrieve information through genetic toxicology is limited. According to the Pathology Tests Explained organization, genetic tests offer information regarding the specific diseases/gene that is being tested. It does not cover information about other genetic diseases that might be present but have not been tested. Similarly, it cannot identify all the variations of genes that cause the diseases, and also it does not showcase the severity of the diseases. Hence, these limitations are anticipated to hamper the growth of the genetic toxicology industry.

Request a free sample copy or view report summary: Genetic Toxicology Testing Market Report

Genetic Toxicology Testing Market Report Highlights

• By type, the in vitro is expected to be the fastest growing segment with the largest share of the Genetic Toxicology Testing Market in 2021. Owing to the rising requirement by regulatory agencies for genotoxicity in the food industry
• By application, the pharmaceutical & biotechnology segment is estimated to become a major market contributor. This is attributed to an increase in the development of cell and gene therapy, coupled with increasing use of pharmacogenomics and personalized medicines
• The Asia Pacific region is projected to grow substantially over the forecasted period owing to the increasing imports of novel food and tightening test regulations for the same, especially in Australia
• By product, the service segment captured a significant proportion of the share in 2021, owing to the increasing demand by pharmaceutical and biotechnology companies for nonclinical works. Also, increasing strategic initiatives by contract research organizations is a major growth determinant
• North America was a major regional market for genetic toxicology in 2021 owing to the availability of efficient players in the region to match the demand by pharma and biotech companies. The increasing R&D in personalized medicines is also a significant factor
• Some of the main market players include Thermo Fisher Scientific, Inc.; Charles River Laboratories International; Laboratory Corp of America Holdings; and Eurofins Scientific

Access Press Release@ https://www.grandviewresearch.com/press-release/global-genetic-toxicology-testing-market

Genetic Toxicology Testing Market Segmentation

Grand View Research has segmented the global genetic toxicology testing market based on type, product, application, and region:

Genetic Toxicology Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• In Vitro
• In Vivo

Genetic Toxicology Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagents & Consumables
• Assays
• Services

Genetic Toxicology Testing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology
• Food Industry
• Cosmetics Industry
• Other

Genetic Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Genetic Toxicology Testing Market

• Thermo Fisher Scientific, Inc.
• Charles River Laboratories International
• Laboratory Corp of America Holdings
• Eurofins Scientific
• Jubilant Life Sciences Limited
• Syngene International Limited
• Gentronix Ltd.
• Inotiv Inc.
• Creative Bioarray
• MB Research Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.